SG103334A1 - Tablet for oral administration comprising 2-[(4-methoxy-2-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole - Google Patents
Tablet for oral administration comprising 2-[(4-methoxy-2-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazoleInfo
- Publication number
- SG103334A1 SG103334A1 SG200200477A SG200200477A SG103334A1 SG 103334 A1 SG103334 A1 SG 103334A1 SG 200200477 A SG200200477 A SG 200200477A SG 200200477 A SG200200477 A SG 200200477A SG 103334 A1 SG103334 A1 SG 103334A1
- Authority
- SG
- Singapore
- Prior art keywords
- methylsulfinyl
- pyrrol
- benzimidazole
- pyridinyl
- methoxy
- Prior art date
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG200200477A SG103334A1 (en) | 2002-01-24 | 2002-01-24 | Tablet for oral administration comprising 2-[(4-methoxy-2-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG200200477A SG103334A1 (en) | 2002-01-24 | 2002-01-24 | Tablet for oral administration comprising 2-[(4-methoxy-2-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole |
Publications (1)
Publication Number | Publication Date |
---|---|
SG103334A1 true SG103334A1 (en) | 2004-04-29 |
Family
ID=32653771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200200477A SG103334A1 (en) | 2002-01-24 | 2002-01-24 | Tablet for oral administration comprising 2-[(4-methoxy-2-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole |
Country Status (1)
Country | Link |
---|---|
SG (1) | SG103334A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022116796A1 (en) * | 2020-12-02 | 2022-06-09 | 丽珠医药集团股份有限公司 | Enteric pellet, preparation method therefor, and preparation comprising same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994002140A1 (en) * | 1992-07-17 | 1994-02-03 | Astra Aktiebolag | Pharmaceutical composition containing antiulcer agent |
US6280773B1 (en) * | 1998-12-29 | 2001-08-28 | Il Yang Pharm. Co., Ltd. | Optimally stabilized microgranule comprising 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazole derivative |
-
2002
- 2002-01-24 SG SG200200477A patent/SG103334A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994002140A1 (en) * | 1992-07-17 | 1994-02-03 | Astra Aktiebolag | Pharmaceutical composition containing antiulcer agent |
US6280773B1 (en) * | 1998-12-29 | 2001-08-28 | Il Yang Pharm. Co., Ltd. | Optimally stabilized microgranule comprising 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazole derivative |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022116796A1 (en) * | 2020-12-02 | 2022-06-09 | 丽珠医药集团股份有限公司 | Enteric pellet, preparation method therefor, and preparation comprising same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200501084B (en) | Dispersible tablets for oral administration | |
HK1085131A1 (en) | Solid drug for oral use | |
AU3574500A (en) | Rapidly disintegrable tablet for oral administration | |
PL374347A1 (en) | Solid pharmaceutical formulations comprising telmisartan | |
TWI349664B (en) | Benzimidazole derivatives: preparation and pharmaceutical applications | |
AU2003229555A1 (en) | Oral administration form for difficulty soluble basic active ingredients which are applied orally | |
PT1362582E (en) | Enrobed solid dosage form | |
IL159725A0 (en) | Pharmaceutical compositions containing benzimidazole derivatives | |
GB0210397D0 (en) | Pharmaceutical formulations | |
EP1553925A4 (en) | Modified release oral dosage form | |
NO20054944D0 (en) | Cladribine formulations for improved oral and transmucosal administration | |
TWI319317B (en) | Modified release pharmaceutical formulation | |
AU2003246978A1 (en) | Pharmaceutical compositions comprising cyclosporin for oral administration | |
IS7481A (en) | Epothilone for oral administration | |
HUP0303948A2 (en) | Solid orally-dispersible pharmaceutical formulation | |
HK1072194A1 (en) | Oral dosage form for controlled drug release | |
GB2392093B (en) | Pharmaceutical formulations | |
IL165069A0 (en) | Immediate release pharmaceutical formulation | |
PL1673349T3 (en) | Benzimidazole derivatives: preparation and pharmaceutical applications | |
SG103334A1 (en) | Tablet for oral administration comprising 2-[(4-methoxy-2-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole | |
EP1652522A4 (en) | Sustained release tablet for oral use | |
EP1491189A4 (en) | Diclofenac sodium oral pharmaceutical | |
SG105539A1 (en) | Stabilized enteric-coated microgranules comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl] methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole and oral formulations comprising the microgranules | |
AU2003254672A8 (en) | Dual-spike release formulation for oral drug delivery | |
GB2394415B (en) | Fast dissolving buccal tablets for rapid drug delivery |